Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_DYSPLASIA_NOS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87.9, N89.3, N90.3 Cause of death: ICD-10 — N87.9, N89.3, N90.3 2 out of 7 registries used, show all original rules.	461
4. Check minimum number of events None	461
5. Include endpoints None	461
6. Filter based on genotype QC (FinnGen only)	461

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_FEMALE_GENITAL_DYSPLASIA_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N879\|N893\|N903
HD_ICD_9
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N879\|N893\|N903
COD_ICD_9
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2793	2793	-
Only index persons	2743	2743	-
Unadjusted period prevalence (%)
Whole population	0.08	0.08	-
Only index persons	0.10	0.10	-
Median age at first event (years)
Whole population	-	41.62	-
Only index persons	-	41.33	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	461	461	-
Unadjusted period prevalence (%)	0.16	0.16	-
Median age at first event (years)	43.10	43.10	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
412: Matched controls
4120

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

5895.5

323.0

339

ULA02

NOMESCO Finland

Kolposcopy

20.9

157.4

288

411

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

14.5

107.5

208

270

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

16.4

93.5

163

158

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

10.4

92.5

224

424

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

9.9

91.2

230

465

LDA10

NOMESCO Finland

Curettage of cervix uteri

11.4

59.9

121

145

N87.0

ICD-10 Finland

Mild cervical dysplasia

12.9

45.0

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

12.8

42.3

N90.3

ICD-10 Finland

Dysplasia of vulva, unspecified

+∞

41.3

N89.3

ICD-10 Finland

Dysplasia of vagina, unspecified

+∞

37.0

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

14.2

33.0

N87.1

ICD-10 Finland

Moderate cervical dysplasia

8.2

25.1

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.7

20.5

232

1334

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

7.8

18.9

A63.0

ICD-10 Finland

Anogenital (venereal) warts

5.2

17.1

119

LEB00

NOMESCO Finland

Biopsy of vagina

7.3

14.6

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

51.7

12.9

LFC00

NOMESCO Finland

Partial excision of vulva

26.8

9.9

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

22.3

9.4

LCA06

NOMESCO Finland

Biopsy of endometrium

2.3

9.1

440

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

24.6

9.0

N90.0

ICD-10 Finland

Mild vulvar dysplasia

22.5

8.1

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

45.9

7.7

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

8.1

7.2

P01AB01

ATC

metronidazole; oral, rectal

1.8

7.1

196

1403

ZXC00

NOMESCO Finland

Use of diathermy

9.0

7.1

SPAT1193

SPAT

Pap smear

2.1

6.8

406

WX702

NOMESCO Finland

Supraglottic ventilation device

3.2

6.8

112

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

22.9

6.7

X86

ICPC

Abnormal cervix smear

6.4

6.5

8071/2-C51.9

ICD-O-3

Differentiated intraepithelial neoplasia of vulva, NOS

70.9

6.4

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

27.1

6.2

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

27.1

6.2

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3025130) Human papilloma virus identified in Specimen

118

10.01

75.50

2.3

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

138

270

6.87

71.96

2.3

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

240

1248

2.93

28.30

2.5

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

3.18

3.68

1.6

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

177

1381

1.46

3.65

4.0

35.9

36.6

g/l

1.06

167

1286

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.53

3.34

1.7

2.0

13.0

13.3

0.61

(40768804) Tissue Pathology biopsy report

213

1748

1.41

3.22

2.9

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

145

1113

1.44

3.18

2.6

2.2

54.5

56.4

u/l

0.33

135

1039

(3037522) Nuclear Ab [Titer] in Serum

628

1.54

3.16

1.4

642.2

563.3

titre

0.10

144

(3009261) Glucose [Presence] in Urine by Test strip

235

1966

1.40

3.16

3.6

3.2

0.0

estimate

0.80

377

(3035350) Ketones [Presence] in Urine by Test strip

231

1930

1.39

3.11

3.7

3.2

0.0

estimate

0.00

379

(4035726)

307

1.71

2.95

1.4

—

(3019150) Specific gravity of Urine by Refractometry

112

831

1.46

2.92

3.7

3.3

1.0

kg/l

1.10

108

(3021601) Nitrite [Presence] in Urine by Test strip

231

1944

1.38

2.91

5.0

4.4

0.0

estimate

0.50

387

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

390

1.62

2.85

2.0

2.2

5.2

umol/l

0.00

335

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

111

827

1.45

2.82

1.3

17.5

29.4

iu/ml

1.33

292

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.43

2.49

1.0

1.1

—

(3018418) pH of Serum or Plasma

127

991

1.39

2.47

4.2

3.4

7.4

1.16

190

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

184

1523

1.35

2.47

3.8

3.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

196

1638

1.34

2.46

5.2

1.2

mmol/l

0.01

170

1383

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

159

1290

1.35

2.42

4.2

2.9

32.7

27.9

u/l

0.62

151

1235

(3029937) Albumin [Presence] in Urine by Test strip

131

1031

1.38

2.41

3.8

3.4

0.0

estimate

1.08

387

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

406

0.52

2.41

3.0

3.6

29.6

33.2

—

288

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

3.26

2.32

1.9

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

209

1.73

2.31

1.8

1.5

—

(4010399)

236

1.66

2.19

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

152

1.82

2.17

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.33

2.15

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

109

848

1.37

2.14

3.7

3.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

321

2917

1.33

2.10

4.1

3.9

10.2

10.1

mm/h

0.10

301

2719

(3013512) EKG study

887

0.69

2.07

2.5

3.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

214

1852

1.29

1.97

4.9

5.3

10.0

9.4

umol/l

0.59

201

1745

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

284

1.57

1.96

2.0

2.2

0.2

g/l

0.03

272

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

344

3677

0.75

1.95

10.1

9.3

90.2

88.8

ml/min/173m2

0.69

263

2963

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

310

1.54

1.92

1.5

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

398

0.58

1.85

2.1

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

312

2847

1.30

1.85

7.2

6.6

72.3

74.1

u/l

0.41

294

2675

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

313

1.52

1.85

1.5

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

501

1.42

1.83

3.5

2.3

1.1

1.0

e6/l

0.16

262

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

322

1.51

1.83

2.6

3.6

4.6

pmol/l

0.07

287

(3002032) Base excess in Venous blood by calculation

216

1.62

1.82

4.2

3.0

2.1

2.3

mmol/l

0.23

171

(1001926) Buprenorphine [Presence] in Urine by Screen method

168

0.41

1.82

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

689

1.36

1.80

1.7

1.6

455.8

46218925.0

pmol/l

1.31

595

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.20

1.79

5.8

2.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.93

1.78

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

117

1.83

1.77

4.1

8.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

235

1.58

1.74

1.7

1.3

1.4

g/l

0.31

216

(3000093) Morphology [Interpretation] in Blood Narrative

3.19

1.66

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.83

1.65

3.6

2.0

472.9

488.5

e6/l

—

(3026008) Bacteria identified in Urine by Culture

136

1132

1.29

1.65

3.0

2.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

103

826

1.32

1.64

1.3

21.2

15.2

u/ml

0.22

349

(3019225) pH of Specimen

310

0.56

1.61

3.0

3.4

—

(3028300) Cannabinoids [Presence] in Urine

214

0.50

1.47

1.3

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

460

1.38

1.46

1.6

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.14

1.45

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.06

1.44

1.1

—

(3027008) Opiates [Presence] in Urine

212

0.51

1.44

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

181

1.58

1.43

3.3

2.4

2.6

4.5

ug/l

1.15

159

(3015736) pH of Urine

174

1514

1.24

1.42

3.7

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

211

0.51

1.42

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

211

0.51

1.42

1.3

1.4

—

(4062490)

2.27

1.41

1.2

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

2.03

1.39

1.4

1.8

0.8

0.7

g/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

272

0.57

1.39

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

403

1.39

1.38

1.4

1.5

—

(3016879) Cocaine [Presence] in Urine

196

0.50

1.38

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

271

0.58

1.37

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

271

0.58

1.37

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

430

1.37

1.2

119.9

152.2

iu/ml

0.29

193

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

270

0.58

1.35

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

318

1.42

1.35

1.8

2.1

1335.9

3848.6

u/l

1.00

134

(3004588) Protein electrophoresis panel - Serum or Plasma

168

1.58

1.34

1.3

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

219

1.50

1.30

4.4

2.9

5.6

5.9

kpa

1.15

213

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

278

1.44

1.29

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

498

1.33

1.27

2.3

2.1

15.4

13.9

umol/l

0.76

463

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

288

0.61

1.25

1.6

1.5

—

(3012544) pH of Venous blood

221

1.48

1.25

3.9

2.9

—

(44813793)

2.24

1.25

1.5

1.0

—

(40761535) Cells panel - Urine sediment

255

1.45

1.24

4.4

3.1

—

(3042936) Bacteria identified in Isolate by Culture

458

1.33

1.20

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

539

1.31

1.20

3.2

3.1

128.1

164.7

ng/l

0.12

317

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

406

1.35

1.18

1.5

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

451

1.33

1.17

2.3

2.1

2.4

2.5

g/l

0.12

420

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.3

—

65.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

1.16

0.0

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.52

1.15

2.0

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

167

1.53

1.15

1.5

—

(3022313) Gas panel - Capillary blood

113

0.44

1.14

1.8

3.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

111

1.65

1.13

2.4

2.2

1.6

1.1

0.71

111

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

185

1.49

1.11

1.9

1.7

—

(4027681)

2.28

1.10

1.1

1.2

—

(3023368) Bacteria identified in Blood by Culture

729

1.26

1.10

3.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

814

1.24

1.09

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

466

1.31

1.08

3.3

2.4

5.2

4.4

e6/l

0.13

227

(3015171) Extractable nuclear Ab [Units/volume] in Serum

195

1.46

1.07

1.4

1.3

2.1

0.9

u/ml

—

(3044889) 12 lead EKG panel

272

2522

1.19

1.07

3.6

3.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

405

1.32

1.05

2.6

2.2

26.1

22.8

0.79

345

(3035320) C reactive protein [Mass/volume] in Body fluid

2.29

1.03

2.2

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.29

1.03

3.0

—

(3035285) Chloride [Moles/volume] in Venous blood

2.07

1.03

1.9

2.4

102.7

106.5

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

2.07

1.03

1.9

2.4

4.1

3.9

mmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.07

1.03

1.3

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.07

1.03

1.9

2.4

—

(3032080) INR in Blood by Coagulation assay

130

1132

1.21

1.02

6.5

5.6

1.0

1.1

inr

0.87

373

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

123

1066

1.21

1.01

1.9

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.19

0.98

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.19

0.98

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.19

0.98

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

565

1.26

0.96

2.4

2.2

128.0

96.5

ug/g

0.20

442

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

218

1.40

0.94

1.7

1.5

—

(3022096) Basophils/100 leukocytes in Blood

194

1762

1.17

0.94

6.3

5.4

0.7

0.23

179

1634

(3019060) Gas panel - Arterial blood

142

1.50

0.94

4.1

4.3

—

(3000991) Gas panel - Venous blood

184

1.44

0.94

5.8

6.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.24

0.93

1.8

1.9

63.7

60.9

—

(3009508) Creatinine [Moles/volume] in Urine

935

0.81

0.92

4.0

2.9

6.8

7.5

mmol/l

0.78

790

(3023419) Bacteria identified in Sputum by Culture

2.16

0.92

7.3

2.7

—

(3037756) Immunofixation for Serum or Plasma

1.92

0.89

1.3

2.1

—

(3024928) Oxygen saturation in Venous blood

1.92

0.89

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

205

1877

1.17

0.88

4.2

3.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.01

0.87

2.0

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.83

0.86

1.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.64

0.85

1.3

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.62

0.82

1.3

1.1

—

12.5

—

(3003396) Base excess in Arterial blood by calculation

269

1.33

0.80

4.5

6.3

1.7

1.3

mmol/l

0.29

210

(3041096) Erythrocytes [Presence] in Urine by Automated

129

1147

1.17

0.80

3.1

2.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.79

0.0

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.2

—

26.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.78

0.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.78

0.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.78

0.0

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.77

0.0

2.7

—

48.2

—

(1002224) Polysomnography panel

197

0.65

0.77

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

232

0.68

0.77

1.6

1.5

—

(3013115) Eosinophils [#/volume] in Blood

220

2042

1.15

0.76

6.1

5.6

0.2

e9/l

0.83

206

1832

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

158

1.41

0.76

1.6

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

390

3778

1.21

0.75

13.9

11.6

39.5

0.05

308

3023

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

491

1.23

0.74

1.6

1.5

1.4

1.3

0.30

443

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

136

0.58

0.74

1.8

1.7

94.0

96.6

—

127

(3014576) Chloride [Moles/volume] in Serum or Plasma

300

1.29

0.73

5.0

5.4

103.7

104.3

mmol/l

0.37

292

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

2.01

0.73

1.6

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

2.01

0.73

12.4

3.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.62

0.72

1.1

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

360

3471

1.17

0.69

15.1

13.0

13.4

13.5

0.83

354

3417

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

119

0.58

0.68

1.3

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

0.53

0.67

1.4

1.6

—

(40758558) Short blood count panel - Blood

111

989

1.16

0.67

5.7

6.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

225

0.70

0.67

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.64

0.67

1.4

—

(3021901) Oxygen saturation in Capillary blood

1.60

0.65

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

583

1.20

0.65

1.8

2.0

—

(3005033) Fetal Nuchal fold Thickness US

223

0.71

0.64

1.6

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

112

1.44

0.64

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.73

0.64

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.73

0.64

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

104

926

1.16

0.64

1.6

1.8

0.7

0.8

mg/l

0.42

696

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

378

3884

0.85

0.63

3.7

3.8

4.8

4.9

mmol/l

0.20

366

3682

(3003740) Influenza virus B Ag [Presence] in Specimen

103

0.58

0.62

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

103

0.58

0.62

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.56

0.62

5.9

4.3

—

(21494755) Public health laboratory ask at order entry panel

561

0.82

0.62

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1.49

0.61

9.2

3.3

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.59

0.0

1.2

—

(4146454)

0.00

0.59

0.0

3.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.58

0.0

2.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.58

0.0

1.1

—

120.6

—

(4034850)

116

0.60

0.58

15.6

5.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

284

2711

1.12

0.58

4.4

4.0

—

(44790048)

1.72

0.58

1.5

1.3

—

(44806118)

1.72

0.58

1.5

1.3

—

(44790047)

1.72

0.58

1.5

1.3

—

(44790049)

1.72

0.58

1.5

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.68

0.57

1.2

1.1

—

1.1

—

(3000330) Specific gravity of Urine by Test strip

159

1.34

0.56

4.2

2.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

349

3378

1.14

0.55

4.5

4.4

14.4

pmol/l

0.07

331

3162

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.59

0.54

1.0

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

425

4175

1.23

0.54

9.6

8.9

24.9

23.8

u/l

0.28

412

4056

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.50

0.54

1.2

164.0

245.0

u/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

351

1.22

0.54

1.8

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

157

1454

1.12

0.53

5.0

4.5

1.2

mmol/l

0.03

143

1329

(3020961) Endomysium IgA Ab [Titer] in Serum

233

1.26

0.52

1.1

—

195.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

270

1.24

0.51

1.9

2.8

1.8

0.03

240

(3026782) Osmolality of Urine

635

1.16

0.51

3.4

2.4

504.9

529.2

mosm/kgh2o

0.45

534

(40768443) Skin Pathology biopsy report

145

0.68

0.51

1.0

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

378

3870

0.87

0.51

3.7

1.5

1.6

mmol/l

0.96

360

3657

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

287

2754

1.11

0.50

2.9

2.8

40.6

35.6

u/l

0.50

273

2625

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

290

1.22

0.49

3.0

4.0

14.4

8.2

ug/l

0.33

228

(36304419) Bacteria [Presence] in Urine

897

1.13

0.48

4.2

2.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.53

0.48

2.1

1.6

2.4

100.8

u/ml

—

(3019069) Monocytes/100 leukocytes in Blood

196

1847

1.11

0.48

6.5

5.5

8.1

8.0

0.28

183

1729

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.50

0.47

1.1

1.3

—

(4268621)

1.50

0.47

1.9

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

405

3970

1.17

0.47

12.4

10.7

22.4

18.8

mg/l

1.25

314

3011

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

182

1.28

0.47

1.4

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

526

1.16

0.47

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.44

0.46

1.7

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.58

0.45

1.2

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

195

1842

1.10

0.45

6.1

5.3

2.7

0.09

181

1712

(3024891) Influenza virus A+B Ag [Presence] in Specimen

128

0.70

0.44

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

213

2024

1.10

0.43

6.2

5.3

1.9

2.0

e9/l

0.44

197

1821

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.44

0.42

1.4

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

125

1158

1.11

0.42

3.1

2.9

89.8

58.0

ng/l

0.17

602

(3013826) Glucose [Moles/volume] in Serum or Plasma

210

1996

1.10

0.42

3.6

3.8

6.5

6.3

mmol/l

0.37

192

1805

(3003694) ABO and Rh group [Type] in Blood

118

1274

0.90

0.42

1.8

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.41

0.0

3.8

—

(3000492) Spirometry study

362

1.18

0.41

1.7

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

201

1909

1.09

0.41

6.0

5.4

30.1

29.5

0.34

188

1777

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.41

0.0

3.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.36

0.41

1.0

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

235

2248

1.09

0.41

8.1

8.3

3.9

e9/l

0.13

214

1985

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

1.31

0.41

1.3

1.1

—

(21494434) Karyotype in Bone marrow

0.00

0.40

0.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

385

3924

0.89

0.40

4.1

2.9

mmol/l

0.05

363

3701

(3002256) Pathology report gross observation

514

1.15

0.40

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.40

0.0

1.9

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

30.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.4

—

(3016750) Collection duration of Urine

0.00

0.39

0.0

2.3

—

506.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.39

0.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

344

0.83

0.39

1.1

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.38

0.38

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

0.73

0.38

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.36

0.37

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

1.40

0.37

1.8

2.0

—

(3022145) Colonoscopy Study observation

423

1.15

0.37

1.4

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

653

1.12

0.36

2.9

3.0

468.3

708.2

ng/l

1.22

543

(3022621) pH of Urine by Test strip

236

1.20

0.36

1.7

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.62

0.35

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

539

1.13

0.35

1.7

1.6

1292.9

1189.7

nmol/l

0.38

410

(3030467) Casts [#/volume] in Urine by Automated count

887

1.10

0.35

4.4

2.6

0.4

0.3

e6/l

0.06

648

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.38

0.35

1.1

—

(3044941) Cell count panel - Synovial fluid

1.34

0.34

1.2

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.34

0.34

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

101

939

1.10

0.33

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

552

1.12

0.32

1.8

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

132

0.75

0.32

1.3

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

128

1.26

0.32

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.33

0.32

1.4

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.33

0.32

1.7

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

888

0.91

0.32

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

733

0.90

0.32

1.6

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.35

0.31

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

240

1.18

0.31

1.7

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.30

0.30

1.0

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

690

1.10

0.30

3.4

2.3

9.8

9.1

e6/l

0.08

600

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.34

0.30

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

152

0.78

0.30

1.1

2.5

0.8

0.1

e6/l

0.52

145

(3018010) Neutrophils/100 leukocytes in Blood

197

1891

1.07

0.29

6.1

5.1

56.1

56.5

0.22

184

1771

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.25

0.29

1.6

4.4

—

3.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.23

0.29

1.7

4.4

36.8

24.4

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.23

0.29

1.6

4.4

55.5

32.2

mg/l

—

(3002582) Erythrocytes [#/volume] in Urine

104

975

1.09

0.29

3.9

2.7

23.1

65.3

e6/l

1.49

722

(40761536) Microorganisms panel - Urine sediment

346

1.14

0.29

4.1

3.3

—

(3014051) Protein [Presence] in Urine by Test strip

1.30

0.28

1.5

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

226

0.83

0.28

1.2

1.7

3.3

2.5

mg/l

0.62

148

(3023520) Reticulocytes [#/volume] in Blood

177

1.20

0.28

1.9

2.9

65.9

76.1

e9/l

0.68

132

(42870588) Differential panel, method unspecified - Blood

128

1212

1.08

0.28

6.3

5.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

120

0.75

0.27

2.3

1.8

—

(3001604) Monocytes [#/volume] in Blood

203

1956

1.07

0.27

6.0

5.3

0.5

e9/l

0.02

184

1728

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

1.21

0.26

2.3

2.1

—

(3045414) Leukocytes [Presence] in Urine

178

1.19

0.26

1.3

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.69

0.26

2.8

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

365

3709

0.92

0.26

3.2

3.4

1.2

mmol/l

0.60

347

3491

(3035941) MCH [Entitic mass]

442

4450

0.84

0.26

18.0

16.1

30.2

30.1

0.75

437

4404

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

368

3737

0.92

0.25

3.8

5.6

5.7

mmol/l

0.10

342

3489

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

177

1702

1.06

0.25

2.4

2.2

76.0

76.3

nmol/l

0.05

163

1569

(3021589) Normoblasts [#/volume] in Blood

165

1715

0.94

0.23

8.9

7.7

0.0

e9/l

1.28

140

1416

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

125

0.80

0.23

2.2

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

125

0.80

0.23

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.29

0.23

1.0

1.1

14.8

16.2

u/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1.29

0.23

1.0

1.2

39.8

59.4

u/l

—

(3006315) Basophils [#/volume] in Blood

203

1966

1.06

0.22

6.1

5.3

0.0

e9/l

0.37

182

1731

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

320

3140

1.06

0.22

3.6

3.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.19

0.21

1.4

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.19

0.21

1.4

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.21

0.0

10.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.21

0.0

2.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

7.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(44806071)

0.00

0.21

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(1761868) Lipid panel - Serum or Plasma

152

1579

0.94

0.21

2.3

2.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.21

0.0

2.5

—

(3007461) Platelets [#/volume] in Blood

442

4446

0.86

0.20

18.1

16.3

267.0

266.6

e9/l

0.04

435

4364

(3021960) Folate [Moles/volume] in Serum or Plasma

744

1.07

0.20

1.5

1.4

24.1

22.0

nmol/l

0.56

644

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.20

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.20

0.0

1.4

—

(3000012) Reticulocyte production index

0.00

0.20

0.0

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

146

1.17

0.19

1.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

846

0.93

0.19

4.6

3.8

10.6

7.2

mg/mmol

0.37

499

(1616796) Gas panel - Central venous blood

1.18

0.19

1.3

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

175

0.85

0.19

1.3

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.24

0.19

1.2

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

337

3420

0.95

0.19

5.0

4.6

38.0

38.1

mmol/mol

0.11

319

3226

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

113

1082

1.06

0.18

1.2

1.3

0.6

1.9

u/ml

1.66

298

(3014765) Yersinia sp identified in Stool by Organism specific culture

132

0.83

0.18

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

474

0.92

0.17

1.3

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

225

0.88

0.16

1.8

1.3

266.1

246.7

miu/ml

—

114

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

277

0.90

0.16

2.5

2.2

85.7

77.6

ml/min/173m2

—

107

(3010813) Leukocytes [#/volume] in Blood

443

4452

0.87

0.16

18.1

16.3

6.7

6.6

e9/l

0.44

433

4353

(3043409) Potassium [Moles/volume] in Arterial blood

0.76

0.15

6.8

3.1

3.4

3.7

mmol/l

—

(4094501)

0.75

0.15

1.3

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.16

0.15

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

443

4451

0.88

0.15

18.1

16.3

132.5

132.9

g/l

0.33

438

4406

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.11

0.15

1.1

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.80

0.14

1.9

3.9

59.1

58.8

—

(3026361) Erythrocytes [#/volume] in Blood

443

4450

0.88

0.14

18.1

16.2

4.4

e12/l

1.35

434

4357

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

103

1.17

0.14

7.2

2.8

24.0

24.2

mmol/l

0.16

(3020891) Body temperature

0.83

0.14

7.4

3.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

835

0.95

0.13

2.2

2.1

298.4

5971.0

umol/l

3.68

745

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

131

1350

0.96

0.13

1.8

90.7

99.2

pmol/l

1.22

702

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.17

0.13

1.1

1.3

—

1.1

—

(3024731) MCV [Entitic volume]

443

4449

0.89

0.13

18.0

16.2

90.7

90.4

0.80

438

4404

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

591

1.06

0.12

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

181

1.11

0.12

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

124

1205

1.04

0.12

2.5

3.1

2.3

2.4

mmol/l

0.89

117

1088

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

732

1.05

0.11

1.9

—

(3037121) Protein [Mass/volume] in Urine

106

1.14

0.10

2.9

3.2

0.1

0.3

g/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.11

0.10

1.4

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.11

0.10

1.2

1.3

—

(4281824)

1.09

0.09

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

213

2097

1.03

0.09

3.0

2.8

87.8

68.0

ug/l

1.08

206

1982

(3044290) Cell count panel - Cerebral spinal fluid

1.15

0.09

1.0

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.06

0.09

1.4

1.7

—

(3021788) Differential panel - Synovial fluid

1.09

0.09

1.3

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

318

0.94

0.08

2.3

2.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

460

0.95

0.08

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.83

0.08

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.10

0.08

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.10

0.08

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

116

1186

0.97

0.08

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

303

1.06

0.08

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.05

0.08

1.4

1.3

—

(4306422)

0.83

0.07

2.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

0.82

0.07

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.08

0.07

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

590

0.96

0.07

2.2

2.4

mmol/l

1.04

525

(40768797) Stomach Pathology biopsy report

511

1.04

0.07

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.04

0.07

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.83

0.07

1.9

3.5

4.0

4.5

e9/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.06

0.07

1.0

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

139

1.08

0.05

1.1

1.2

—

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

139

1.08

0.05

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

100

982

1.02

0.05

1.8

1.6

1.3

1.4

mmol/l

0.10

855

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

323

0.96

0.05

3.8

2.1

38.2

31.4

u/l

0.56

270

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

258

1.05

0.05

2.6

3.6

1.2

mmol/l

0.97

224

(3012516) Albumin [Mass/volume] in Urine

806

0.98

0.04

4.1

3.1

72.7

221.0

mg/l

0.57

491

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

121

1.08

0.03

4.9

7.4

23.4

24.1

mmol/l

0.67

115

(3025941) Bacteria identified in Stool by Culture

250

1.04

0.03

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

280

0.96

0.03

1.9

1.4

—

(40761511) CBC panel - Blood by Automated count

420

4210

0.97

0.03

11.3

10.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

103

1018

1.02

0.02

3.4

4.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

222

1.04

0.02

4.3

5.3

1.2

mmol/l

0.06

212

(3007164) IgA [Mass/volume] in Serum or Plasma

920

0.99

0.02

1.5

1.4

2.7

2.2

g/l

1.59

584

(3018095) Leukocytes [#/volume] in Urine

125

1240

1.01

0.02

4.4

3.2

62.1

62.7

e6/l

0.01

804

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

402

1.02

0.01

5.9

4.8

—

(3000494) Fungus identified in Specimen by Culture

432

1.02

0.01

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

163

1.04

0.01

2.5

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

267

0.97

0.01

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

186

0.97

0.00

1.2

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

385

3856

0.99

0.00

5.2

5.1

1.7

2.0

mu/l

0.54

365

3633

(46235355) HIV 1 and 2 tests - Meaningful Use set

112

1114

1.01

0.00

2.1

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.03

0.00

1.1

1.4

3.3

3.7

mmol/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

194

0.98

0.00

8.4

7.1

8.5

7.5

mmol/l

0.24

184

(3023103) Potassium [Moles/volume] in Serum or Plasma

390

3902

1.00

0.00

12.8

10.8

3.9

mmol/l

0.22

381

3783

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

892

1.00

0.00

2.3

2.0

2.7

2.8

mg/l

0.32

771

(3050129) First trimester maternal screen panel - Serum or Plasma

309

1.00

0.00

1.4

1.5

—

(36660697) Celiac disease serology panel - Serum

371

1.00

0.00

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

389

3887

1.00

0.00

12.7

10.8

139.4

139.7

mmol/l

1.24

380

3779

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.86

0.00

1.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.91

0.00

2.8

3.5

15.7

94.4

u/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.92

0.00

1.3

1.8

—

(4133840)

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.98

0.00

1.2

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.7

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.0

1.1

—

132.7

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.1

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.0

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

0.0

2.9

—

(3008898) HLA-B27 [Presence]

230

1.00

0.00

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.0

2.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.0

4.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

2.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.00

0.00

2.2

2.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.90

0.00

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.01

0.00

1.4

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.02

0.00

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.5

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.00

0.00

1.5

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.98

0.00

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

-0.00

0.0

2.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

16.9

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

4.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

2.0

—

1.2

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

15.9

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

2.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_DYSPLASIA_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_FEMALE_GENITAL_DYSPLASIA_NOS	1.288 [1.06, 1.57]	0.012
Birth year	0.995 [0.99, 1.0]	0.254

During the follow-up period (1.1.1998 — 31.12.2019), 177 out of 2382 females with N14_FEMALE_GENITAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_DYSPLASIA_NOS.

N-year risk	Females	Males
1	0.127%	No data
5	0.817%	No data
10	2.041%	No data
15	3.893%	No data
20	6.818%	No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints